Recursion

formerly Recursion PharmaIPO

Decoding biology to radically improve lives

Recursion is an artificial intelligence company in Salt Lake City, United States, founded in 2013. It has raised $497.9M across 8 rounds, most recently a $50.0M Corporate Round in July 2023.

Employees
501–1000
Founded
2013
Business Model
B2B
Total Funding
$497.9M
Last Round
$50.0M Corporate RoundJul 2023
Rounds
8
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 8 funding rounds and 15 investors for this company. to use credits for reveals, or explore the API.

About

Recursion is a TechBio company that combines large-scale biological experimentation, proprietary datasets, and AI-driven machine learning to accelerate drug discovery and development. Operating its Recursion OS platform and BioHive-2 supercomputer built with NVIDIA, the company has generated over 50 petabytes of biological and chemical data to identify novel drug candidates and advance a pipeline of potential first-in-class therapies.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundPost-IPO Equity (NVIDIA)Jul 2023
$50.0M

9 more events

  • IPO2021
  • Series D202010 investors
  • Series C201911 investors

Funding: Seed through Corporate Round. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

14 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×3
  • AI/ML ×2
  • Backend ×2
  • Cloud/Infrastructure ×2
  • Other ×2
  • Engineering & DevOps ×1
  • +2 more

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Acquisitions

Companies in related industries

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Biotech
Series ATotal funding$1.0BApr 2024
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech
Series BTotal funding$612.0MOct 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Recursion on Indexed.vc
<a href="https://indexed.vc/companies/recursion"><img src="https://indexed.vc/api/badge/company/recursion" alt="Recursion on Indexed.vc" width="260" height="76" /></a>